225 related articles for article (PubMed ID: 36693363)
1. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
[TBL] [Abstract][Full Text] [Related]
2. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms.
Machado I; Agaimy A; Giner F; Navarro S; Michal M; Bridge J; Claramunt R; López-Guerrero JA; Alcacer J; Linos K; Llombart-Bosch A
Virchows Arch; 2023 Nov; ():. PubMed ID: 37940743
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
4. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
[TBL] [Abstract][Full Text] [Related]
6. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
[TBL] [Abstract][Full Text] [Related]
9. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
[TBL] [Abstract][Full Text] [Related]
10. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis.
Kerr DA; Cloutier JM; Margolis M; Mata DA; Rodrigues Simoes NJ; Faquin WC; Dias-Santagata D; Chopra S; Charville GW; Wangsiricharoen S; Lazar AJ; Wang WL; Rosenberg AE; Tse JY
Mod Pathol; 2024 Feb; 37(2):100386. PubMed ID: 37992966
[TBL] [Abstract][Full Text] [Related]
11. A Malignant Neoplasm From the Jejunum With a
Prall OWJ; McEvoy CRE; Byrne DJ; Iravani A; Browning J; Choong DY; Yellapu B; O'Haire S; Smith K; Luen SJ; Mitchell PLR; Desai J; Fox SB; Fellowes A; Xu H
Int J Surg Pathol; 2020 Aug; 28(5):553-562. PubMed ID: 31931637
[TBL] [Abstract][Full Text] [Related]
12. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
13. Expanding the spectrum of GLI1-altered mesenchymal tumors-A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract.
Punjabi LS; Goh CHR; Sittampalam K
Genes Chromosomes Cancer; 2023 Feb; 62(2):107-114. PubMed ID: 36222065
[TBL] [Abstract][Full Text] [Related]
14. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
Mod Pathol; 2024 Apr; 37(6):100494. PubMed ID: 38621503
[TBL] [Abstract][Full Text] [Related]
15. GLI1-Altered Mesenchymal Tumors.
Cloutier JM; Kerr DA
Surg Pathol Clin; 2024 Mar; 17(1):13-24. PubMed ID: 38278602
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
17. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
18. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
[TBL] [Abstract][Full Text] [Related]
19. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
[TBL] [Abstract][Full Text] [Related]
20. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
